Issue Archive
May 2011 | Volume 10 | Issue 5
Original Articles
Program Spotlight: Nova Southeastern University, College of Osteopathic Medicine and Broward General Medical Center Dermatology Residency Training Program
Advances in the Treatment of Keloids
Occurring with higher proportions in skin of color, keloid formation is seen in individuals of all races, with the lowest incidence in albinos. Interestingly, prevalence of keloids is correlated to s...
Read MoreTopical Retinoids for Pigmented Skin
Topical retinoids are an important class of drugs for treating several dermatoses occurring more frequently in patients with pigmented skin, such as melasma, post-inflammatory hyperpigmentation, pseud...
Read MoreAutoimmune-Mediated Blisters (for the Boards)
Fillers in the Skin of Color Population
The skin of color population in the United States is rapidly growing and the cosmetic industry is responding to the demand for skin of color targeted treatments. The aging face in skin of color patien...
Read MoreProgressive Macular Hypomelanosis
Progressive macular hypomelanosis is an under-recognized disorder characterized by the presence of numerous ill-defined hypopigmented macules and patches on the trunk of young adults. Although common...
Read MoreTopical Tacrolimus Is More Effective for Treatment of Vitiligo in Patients of Skin of Color
Background: Vitiligo vulgaris is a chronic autoimmune depigmenting disorder affecting individuals of all skin colors. Lesions are commonly noted in the periorificial face and over the upper and lower ...
Read MoreScalp Hyperkeratosis and Alopecia in Children of Color
Background: Scalp hyperkeratosis and/or alopecia are common pediatric dermatologic findings. In Caucasian children, scalp hyperkeratosis of childhood is most often associated with atopic and seborrhe...
Read MoreMelasma in Latin Americans
Melasma is an acquired skin condition characterized by irregular brown or hyperpigmented patches typically located on the forehead, cheeks, nose, chin and upper lip. The pathogenesis of melasma is not...
Read MoreA Survey of Skin Conditions and Concerns in South Asian Americans: A Community-Based Study
Background: South Asians represent a rapidly growing part of the U.S. population, increasing 188 percent from 1990 to 2000 (0.27% to 0.78%). Studies investigating the epidemiology of skin disorders in...
Read MoreAn Over-the-Counter Moisturizer Is as Clinically Effective as, and More Cost-Effective Than, Prescription Barrier Creams in the Treatment of Children With Mild-to-Moderate Atopic Dermatitis: A Randomized, Controlled Trial
Background: Atopic dermatitis (AD) is a prevalent skin disorder with significant cost of treatment. Several prescription device moisturizers have been approved by the FDA to treat AD but are significa...
Read MoreInfliximab Treatment for Psoriasis in 120 Patients on Therapy for a Minimum of One Year: A Review
Infliximab is a chimeric monoclonal antibody, which acts by binding to both the soluble and membrane-bound tumor necrosis factor-a. In clinical practice, it is used as either monotherapy or in combina...
Read MorePyoderma Gangrenosum Following Breast Reconstructive Surgery: A Case Report of Treatment With Immunosuppression and Adjunctive Xenogeneic Matrix Scaffolds
NEWS, VIEWS & REVIEWS
News, Views and Reviews provides focused updates, topic reviews and editorials concerning the latest developments in dermatologic therapy....
Read More
Features
PIPELINE PREVIEWS
Pipeline Previews brings to you information on the newest drugs and medical products as they become available to the dermatologic community. This department may include additional information from the...
Read More
